Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Endocrinology and Metabolism|May 31, 2018
Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor XenograftsLaura A Marlow, Stephen D Rohl, James L Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2023
Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine TherapyLaura Boucai, Mahesh Saqcena, Fengshen Kuo, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
UTX Epigenetically Imposes a Cytolytic Effector Program in Autoreactive Stem-like CD8+ T cell ProgenitorsHo-Chung Chen, Hsing Hui Wang, Lisa A Kohn, et al.
The Journal of Clinical Investigation|November 23, 2011
Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activationDebyani Chakravarty, Elmer Santos, Mabel Ryder, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Polyfunctional IL-21+ IFNG+ T follicular helper cells contribute to checkpoint inhibitor diabetes mellitus and can be targeted by JAK inhibitor therapyNicole Huang, Jessica Ortega, Kyleigh Kimbrell, et al.
Journal for Immunotherapy of Cancer|August 2, 2020
Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinomaSara Bedrose, Kevin Charles Miller, Lina Altameemi, et al.
The Journal of Clinical Endocrinology and Metabolism|August 12, 2024
Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid CancerBhavana Konda, Eric J Sherman, Erminia Massarelli, et al.
JAMA Otolaryngology-- Head & Neck Surgery|June 29, 2023
Prognostic Value of Preoperative Molecular Testing and Implications for Initial Surgical Management in Thyroid Nodules Harboring Suspected (Bethesda V) or Known (Bethesda VI) Papillary Thyroid CancerMax A Schumm, Michelle L Shu, Elena G Hughes, et al.
The Lancet. Diabetes & Endocrinology|May 3, 2025
Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statementSophie Leboulleux, Laura Boucai, Naifa Busaidy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2012
An in vivo immunotherapy screen of costimulatory molecules identifies Fc-OX40L as a potent reagent for the treatment of established murine gliomasKatherine A Murphy, Melissa G Lechner, Flavia E Popescu, et al.
Pageof 11